Durvalumab Plus Tremelimumab in Advanced or Metastatic Soft Tissue and Bone Sarcomas: a Single-Centre Phase 2 Trial.
Neeta Somaiah,Anthony P. Conley,Edwin Roger Parra,Heather Lin,Behrang Amini,Luisa Solis Soto,Ruth Salazar,Carmelia Barreto,Honglei Chen,Swati Gite,Cara Haymaker,Elise F. Nassif,Chantale Bernatchez,Akash Mitra,John Andrew Livingston,Vinod Ravi,Dejka M. Araujo,Robert Benjamin,Shreyaskumar Patel,Maria A. Zarzour,Sharjeel Sabir,Alexander J. Lazar,Wei-Lien Wang,Najat C. Daw,Xiao Zhou,Christina L. Roland,Zachary A. Cooper,Jaime Rodriguez-Canales,Andrew Futreal,Jean-Charles Soria,Ignacio I. Wistuba,Patrick Hwu The Lancet Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper